✦ LIBER ✦

Once-monthly risedronic acid noninferior to daily risedronic acid for postmenopausal osteoporosis

Book ID: 120844955
Publisher: Adis International Limited (now part of Wolters Kluwer Health)
Year: 2007
Weight: 133 KB
Volume: &NA;
Category: Article
ISSN: 1173-8324
DOI: 10.2165/00128413-200716150-00007

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Monthly and daily risedronic acid compar

Monthly and daily risedronic acid comparable in osteoporosis

📂 Article 📅 2006 🏛 Adis International Limited (now part of Wolters Kl ⚖ 120 KB

Once-weekly alendronic acid more effecti

Once-weekly alendronic acid more effective than daily risedronic acid in the treatment of postmenopausal osteoporosis

📂 Article 📅 2002 🏛 Adis International Limited (now part of Wolters Kl ⚖ 151 KB

Alendronic acid superior to risedronic a

Alendronic acid superior to risedronic acid for osteoporosis

📂 Article 📅 2002 🏛 Adis International Limited (now part of Wolters Kl ⚖ 180 KB

A candidate identification questionnaire

A candidate identification questionnaire for patients with postmenopausal osteoporosis switched from treatment with a daily or weekly bisphosphonate to once-monthly ibandronate

✍ Y. Gokce Kutsal; N. Eskiyurt; J. Irdesel; V. Sepici; H. Ugurlu; Y. Kirazli; F. A 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 76 KB

Relationship of changes in total hip bon

Relationship of changes in total hip bone mineral density to vertebral and nonvertebral fracture risk in women with postmenopausal osteoporosis treated with once-yearly zoledronic acid 5 mg: The HORIZON-Pivotal Fracture Trial (PFT)

✍ Richard M Jacques; Steven Boonen; Felicia Cosman; Ian R Reid; Douglas C Bauer; D 📂 Article 📅 2012 🏛 American Society for Bone and Mineral Research 🌐 English ⚖ 244 KB